4//SEC Filing
Recurium Equity, LLC 4
Accession 0001725160-20-000024
CIK 0001725160other
Filed
Oct 29, 8:00 PM ET
Accepted
Oct 30, 7:53 PM ET
Size
5.1 KB
Accession
0001725160-20-000024
Insider Transaction Report
Form 4
Recurium Equity, LLC
10% Owner
Transactions
- Other
Common Stock
2020-10-28−4,147,940→ 14,990 total
Footnotes (1)
- [F1]Recurium Equity, LLC distributed these shares to its members on a pro rata basis, for no consideration.
Documents
Issuer
Zentalis Pharmaceuticals, Inc.
CIK 0001725160
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001808095
Filing Metadata
- Form type
- 4
- Filed
- Oct 29, 8:00 PM ET
- Accepted
- Oct 30, 7:53 PM ET
- Size
- 5.1 KB